Unleashing anti-tumour immunity: dietary restriction and exercise interventions adjunct to chemotherapy for cancer patients.


Journal

Exercise immunology review
ISSN: 1077-5552
Titre abrégé: Exerc Immunol Rev
Pays: Germany
ID NLM: 9505535

Informations de publication

Date de publication:
2024
Historique:
medline: 2 8 2024
pubmed: 2 8 2024
entrez: 2 8 2024
Statut: ppublish

Résumé

Conventional chemotherapies can stimulate the immune system by increasing tumour antigenicity (e.g., neoantigen exposure to immune cells) and altering adjuvanticity in the tumour (e.g., danger associated molecular patterns and cytokines). These molecules promote the recruitment, activation, and maturation of dendritic cells, which in turn, prime and activate cytotoxic T cells against tumour cells. However, several factors can decrease the immunostimulatory efficacy of chemotherapeutic agents. These include reduced tumour cell antigenicity and adjuvanticity and compromised immune function at a local and systemic level. Findings from preclinical studies show that dietary restriction and exercise promote systemic changes that may help to restore immune system function through several mechanisms, including an enhanced infiltration and function of antitumoral immune cells and a decrease in immunosuppressive cells, leading to a reduction in tumour volume. In addition, dietary restriction and exercise training in mice have been shown to enhance the efficacy of chemotherapy. In human studies there is also emerging evidence that dietary restriction and exercise can impact the immune system towards a more antitumoral profile. In this review, we discuss the immunostimulatory effects of dietary restriction (caloric restriction and fasting) and exercise training in preclinical cancer models, and potential synergies with chemotherapy. We then review clinical studies assessing the effects of these interventions on immune-related endpoints and tumour responses. Finally, we propose that combining dietary restriction with exercise could be a promising strategy to increase chemotherapy efficacy.

Identifiants

pubmed: 39094178

Substances chimiques

Antineoplastic Agents 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

26-48

Informations de copyright

Copyright © 2016 International Society of Exercise and Immunology. All rights reserved.

Auteurs

Cristina Crespo-Garcia (C)

Exercise Medicine Research Institute, Edith Cowan University, Perth, Western Australia, Australia.
School of Medical and Health Sciences, Edith Cowan University, Perth, Western Australia, Australia.

John P Campbell (JP)

Department for Health, University of Bath, Bath, United Kingdom.

Dennis R Taaffe (DR)

Exercise Medicine Research Institute, Edith Cowan University, Perth, Western Australia, Australia.
School of Medical and Health Sciences, Edith Cowan University, Perth, Western Australia, Australia.

Carolyn J Peddle-McIntyre (CJ)

Exercise Medicine Research Institute, Edith Cowan University, Perth, Western Australia, Australia.
School of Medical and Health Sciences, Edith Cowan University, Perth, Western Australia, Australia.

Emily Jeffery (E)

Curtin School of Population Health, Curtin University, Perth, Western Australia, Australia.

Daniel A Galvao (DA)

Exercise Medicine Research Institute, Edith Cowan University, Perth, Western Australia, Australia.
School of Medical and Health Sciences, Edith Cowan University, Perth, Western Australia, Australia.

Andrew D Redfern (AD)

School of Medicine and Pharmacology, University of Western Australia, Perth, Western Australia, Australia.

Robert U Newton (RU)

Exercise Medicine Research Institute, Edith Cowan University, Perth, Western Australia, Australia.
School of Medical and Health Sciences, Edith Cowan University, Perth, Western Australia, Australia.
School of Human Movement and Nutrition Sciences, University of Queensland, Brisbane, Queensland, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH